Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription

Articles published in Virus Res

Retrieve available abstracts of 198 articles:
HTML format

Single Articles

    August 2024
  1. LEIST SR, Schafer A, Risemberg EL, Bell TA, et al
    Sarbecovirus disease susceptibility is conserved across viral and host models.
    Virus Res. 2024;346:199399.
    PubMed     Abstract available

    July 2024
  2. WANG Y, Yu H, Zhang T, Sun Z, et al
    Associations between genetic mutations in different SARS-CoV-2 strains and negative conversion time of viral RNA among imported cases in Hangzhou: A cross-sectional study.
    Virus Res. 2024;345:199400.
    PubMed     Abstract available

  3. CHIEN Y, Huang XY, Yarmishyn AA, Chien CS, et al
    Paracrinal regulation of neutrophil functions by coronaviral infection in iPSC-derived alveolar type II epithelial cells.
    Virus Res. 2024;345:199391.
    PubMed     Abstract available

  4. CHIRUMBOLO S, Franzini M, Tirelli U
    Does PI-ME/CFS recall post-COVID (PASC) syndrome?
    Virus Res. 2024;345:199393.

  5. BAI H, Zhang X, Gong T, Ma J, et al
    A systematic mutation analysis of 13 major SARS-CoV-2 variants.
    Virus Res. 2024;345:199392.
    PubMed     Abstract available

    June 2024
  6. TAKADATE Y, Mine J, Tsunekuni R, Sakuma S, et al
    Genetic diversity of H5N1 and H5N2 high pathogenicity avian influenza viruses isolated from poultry in Japan during the winter of 2022-2023.
    Virus Res. 2024;347:199425.
    PubMed     Abstract available

  7. RIVETTI AV JR, Reischak D, de Oliveira CHS, Otaka JNP, et al
    Phylodynamics of avian influenza A(H5N1) viruses from outbreaks in Brazil.
    Virus Res. 2024;347:199415.
    PubMed     Abstract available

  8. KHAIRNAR K, Tomar SS
    COVID-19 genome surveillance: A geographical landscape and mutational mapping of SARS-CoV-2 variants in central India over two years.
    Virus Res. 2024;344:199365.
    PubMed     Abstract available

  9. LUO L, Lv J
    An evolutionary theory on virus mutation in COVID-19.
    Virus Res. 2024;344:199358.
    PubMed     Abstract available

  10. SCHAFER A, Gralinski LE, Leist SR, Hampton BK, et al
    Genetic loci regulate Sarbecovirus pathogenesis: A comparison across mice and humans.
    Virus Res. 2024;344:199357.
    PubMed     Abstract available

  11. SCHMITZ T, Freuer D, Gosslau Y, Warm TD, et al
    Can inflammatory plasma proteins predict Long COVID or Fatigue severity after SARS-CoV-2 infection?
    Virus Res. 2024;344:199363.
    PubMed     Abstract available

  12. KHEMIRI H, Mangone I, Gdoura M, Mefteh K, et al
    Dynamic of SARS-CoV-2 variants circulation in Tunisian pediatric population, during successive waves, from March 2020 to September 2022.
    Virus Res. 2024;344:199353.
    PubMed     Abstract available

    May 2024
  13. XU C, Wang Z, Yu B, Pan Z, et al
    Simultaneous and ultrafast detection of pan-SARS-coronaviruses and influenza A/B viruses by a novel multiplex real-time RT-PCR assay.
    Virus Res. 2024 May 28:199410. doi: 10.1016/j.virusres.2024.199410.
    PubMed     Abstract available

  14. LIN X, Yang F, Yan S, Wu H, et al
    Preparation and characterization of mouse-derived monoclonal antibodies against the hemagglutinin of the H1N1 influenza virus.
    Virus Res. 2024;345:199402.
    PubMed     Abstract available

  15. WU CC, Tam EH, Shih YY, Lin YR, et al
    Exploration of influenza A virus PA protein-associated cellular proteins discloses its impact on mitochondrial function.
    Virus Res. 2024 May 6:199387. doi: 10.1016/j.virusres.2024.199387.
    PubMed     Abstract available

  16. GLENET M, Lebreil AL, N'Guyen Y, Meyer I, et al
    Structural impact of a new spike Y170W mutation detected in early emerging SARS-CoV-2 Omicron variants in France.
    Virus Res. 2024;343:199354.
    PubMed     Abstract available

  17. KUZIKOV M, Reinshagen J, Wycisk K, Corona A, et al
    Drug repurposing screen to identify inhibitors of the RNA polymerase (nsp12) and helicase (nsp13) from SARS-CoV-2 replication and transcription complex.
    Virus Res. 2024;343:199356.
    PubMed     Abstract available

    April 2024
  18. WANG Z, Sun W, Li D, Sun Y, et al
    A live attenuated influenza B virus vaccine expressing RBD elicits protective immunity against SARS-CoV-2 in mice.
    Virus Res. 2024;345:199378.
    PubMed     Abstract available

  19. PAYEN SH, Adhikari K, Petereit J, Uppal T, et al
    SARS-CoV-2 superinfection in CD14(+) monocytes with latent human cytomegalovirus (HCMV) promotes inflammatory cascade.
    Virus Res. 2024;345:199375.
    PubMed     Abstract available

  20. LIU D, Leung KY, Lam HY, Zhang R, et al
    Interaction and antiviral treatment of coinfection between SARS-CoV-2 and influenza in vitro.
    Virus Res. 2024;345:199371.
    PubMed     Abstract available

  21. ZHANG S, Wang P, Shi L, Wang C, et al
    Exploring COVID-19 causal genes through disease-specific Cis-eQTLs.
    Virus Res. 2024;342:199341.
    PubMed     Abstract available

  22. MONTENEGRO AFL, Clementino MAF, Yaochite JNU
    Type I interferon pathway genetic variants in severe COVID-19.
    Virus Res. 2024;342:199339.
    PubMed     Abstract available

  23. LIM T, Rajoriya S, Kim B, Natasha A, et al
    In vitro broad-spectrum antiviral activity of MIT-001, a mitochondria-targeted reactive oxygen species scavenger, against severe acute respiratory syndrome coronavirus 2 and multiple zoonotic viruses.
    Virus Res. 2024;342:199325.
    PubMed     Abstract available

    March 2024
  24. JANSEN JM, Meineke R, Molle A, van de Sandt CE, et al
    Selective pressure mediated by influenza virus M1(58-66) epitope-specific CD8(+)T cells promotes accumulation of extra-epitopic amino acid substitutions associated with viral resistance to these T cells.
    Virus Res. 2024;343:199355.
    PubMed     Abstract available

  25. LARBI I, Marwa A, Souai O, Tougorti H, et al
    Phylogeographic Dynamics of H9N2 Avian Influenza Viruses in Tunisia.
    Virus Res. 2024 Mar 9:199348. doi: 10.1016/j.virusres.2024.199348.
    PubMed     Abstract available

  26. WANG X, Cheng J, Shen L, Chen M, et al
    Rab5c promotes RSV and ADV replication by autophagy in respiratory epithelial cells.
    Virus Res. 2024;341:199324.
    PubMed     Abstract available

  27. HUANG X, Kantonen J, Nowlan K, Nguyen NA, et al
    Mucosal-Associated Invariant T Cells are not susceptible in vitro to SARS-CoV-2 infection but accumulate into the lungs of COVID-19 patients.
    Virus Res. 2024;341:199315.
    PubMed     Abstract available

    February 2024
  28. LI ZA, Bajpai AK, Wang R, Liu Y, et al
    Systems Genetics of Influenza A Virus-infected Mice Identifies TRIM21 as a Critical Regulator of Pulmonary Innate Immune Response.
    Virus Res. 2024 Feb 6:199335. doi: 10.1016/j.virusres.2024.199335.
    PubMed     Abstract available

  29. CEBALLOS-GARZON A, Comtet-Marre S, Peyret P
    Applying targeted gene hybridization capture to viruses with a focus to SARS-CoV-2.
    Virus Res. 2024;340:199293.
    PubMed     Abstract available

  30. ZHANG DQ, Ma QH, Yang MC, Belyakova YY, et al
    Peroxide derivatives as SARS-CoV-2 entry inhibitors.
    Virus Res. 2024;340:199295.
    PubMed     Abstract available

  31. DE ALMEIDA MARQUES DP, Andrade LAF, Reis EVS, Clarindo FA, et al
    New anti-SARS-CoV-2 aminoadamantane compounds as antiviral candidates for the treatment of COVID-19.
    Virus Res. 2024;340:199291.
    PubMed     Abstract available

    January 2024
  32. KODSI IA, Rayes DE, Koweyes J, Khoury CA, et al
    Tracking SARS-CoV-2 variants during the 2023 flu season and beyond in Lebanon.
    Virus Res. 2024;339:199289.
    PubMed     Abstract available

  33. CHRIST W, Klingstrom J, Tynell J
    SARS-CoV-2 variant-specific differences in inhibiting the effects of the PKR-activated integrated stress response.
    Virus Res. 2024;339:199271.
    PubMed     Abstract available

  34. CAI Z, Bai H, Ren D, Xue B, et al
    Integrin alphavbeta1 facilitates ACE2-mediated entry of SARS-CoV-2.
    Virus Res. 2024;339:199251.
    PubMed     Abstract available

  35. ESSAIDI-LAZIOSI M, Perez-Rodriguez FJ, Alvarez C, Sattonnet-Roche P, et al
    Distinct phenotype of SARS-CoV-2 Omicron BA.1 in human primary cells but no increased host range in cell lines of putative mammalian reservoir species.
    Virus Res. 2024;339:199255.
    PubMed     Abstract available

    December 2023
  36. KRISTENSEN C, Larsen LE, Trebbien R, Jensen HE, et al
    The avian influenza A virus receptor SA-alpha2,3-Gal is expressed in the porcine nasal mucosa sustaining the pig as a mixing vessel for new influenza viruses.
    Virus Res. 2023 Dec 22:199304. doi: 10.1016/j.virusres.2023.199304.
    PubMed     Abstract available

  37. OTA K, Sakai H, Sasaki D, Mitsumoto-Kaseida F, et al
    Rapid increase in salivary IgA and broad recognition of spike protein following SARS-CoV-2 vaccination.
    Virus Res. 2023 Dec 4:199294. doi: 10.1016/j.virusres.2023.199294.
    PubMed     Abstract available

    November 2023
  38. LI X, Ye Z, Plant EP
    5' copyback defective viral genomes are major component in clinical and non-clinical influenza samples.
    Virus Res. 2023;339:199274.
    PubMed     Abstract available

    October 2023
  39. NEDAEI F, Esmaeili Rastaghi AR, Goodarzi E, Haji Mullah Asadullah H, et al
    Introduction and effect of natural selection analysis at common mutations of SARS-CoV-2 spike gene in Iran.
    Virus Res. 2023;336:199202.
    PubMed     Abstract available

  40. CAO J, Gu H, Zhang X, Yun H, et al
    Intranasal inoculation of female BALB/c mice with replication-deficient human adenovirus type 5 expressing SARS-CoV-2 nucleocapsid protein aggravates lung pathology upon re-encountering the antigen.
    Virus Res. 2023;335:199201.
    PubMed     Abstract available

    September 2023
  41. TAKAZAWA S, Kotaki T, Nakamura S, Utsubo C, et al
    Construction of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication analyses in biosafety level 2 facilities.
    Virus Res. 2023;334:199176.
    PubMed     Abstract available

  42. STINCARELLI MA, Quagliata M, Di Santo A, Pacini L, et al
    SARS-CoV-2 inhibitory activity of a short peptide derived from internal fusion peptide of S2 subunit of spike glycoprotein.
    Virus Res. 2023;334:199170.
    PubMed     Abstract available

  43. ANDRADE-MOLINA DA, Morey-Leon GA, Munoz-Mawyin KE, Cruz-Fatuly FF, et al
    First sequenced cases of Omicron BA.2 sublineage in Ecuador.
    Virus Res. 2023;334:199169.
    PubMed     Abstract available

  44. WANG Z, Pan Q, Ma L, Zhao J, et al
    Anthracyclines inhibit SARS-CoV-2 infection.
    Virus Res. 2023;334:199164.
    PubMed     Abstract available

  45. BERNAL KDE, Whitehurst CB
    Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients.
    Virus Res. 2023;334:199157.
    PubMed     Abstract available

  46. STRAKOVA P, Bednar P, Kotoucek J, Holoubek J, et al
    Antiviral activity of singlet oxygen-photogenerating perylene compounds against SARS-CoV-2: Interaction with the viral envelope and photodynamic virion inactivation.
    Virus Res. 2023;334:199158.
    PubMed     Abstract available

    August 2023
  47. LEE MM, Cho WK, Cha MH, Yim NH, et al
    The antiviral activity of Thuja orientalis folium against Influenza A virus.
    Virus Res. 2023 Aug 13:199199. doi: 10.1016/j.virusres.2023.199199.
    PubMed     Abstract available

  48. TAKAHASHI T, Akagawa M, Kimura R, Sada M, et al
    Molecular evolutionary analyses of the fusion protein gene in human respirovirus 1.
    Virus Res. 2023;333:199142.
    PubMed     Abstract available

  49. KO MK, Kim HW, Park SH, Park JH, et al
    The role of zinc sulfate in enhancing cellular and humoral immune responses to foot-and-mouth disease vaccine.
    Virus Res. 2023 Aug 1:199189. doi: 10.1016/j.virusres.2023.199189.
    PubMed     Abstract available

    July 2023
  50. MOEINI S, Mohebbi A, Farahmand B, Mehrbod P, et al
    Phylogenetic analysis and docking study of neuraminidase gene of influenza A/H1N1 viruses circulating in Iran from 2010 to 2019.
    Virus Res. 2023 Jul 23:199182. doi: 10.1016/j.virusres.2023.199182.
    PubMed     Abstract available

  51. PRINS MLM, Prins C, de Vries JJC, Visser LG, et al
    Establishing immunogenicity and safety of needle-free intradermal delivery by nanoporous ceramic skin patch of mRNA SARS-CoV-2 vaccine as a revaccination strategy in healthy volunteers.
    Virus Res. 2023 Jul 18:199175. doi: 10.1016/j.virusres.2023.199175.
    PubMed     Abstract available

  52. GORI SAVELLINI G, Anichini G, Cusi MG
    SARS-CoV-2 omicron sub-lineages differentially modulate interferon response in human lung epithelial cells.
    Virus Res. 2023;332:199134.
    PubMed     Abstract available

  53. LI J, Li X, Mao H, Huang C, et al
    SARS-CoV-2 omicron BA.1.1 is highly resistant to antibody neutralization of convalescent serum from the origin strain.
    Virus Res. 2023;332:199131.
    PubMed     Abstract available

    June 2023
  54. JITOBAOM K, Sirihongthong T, Boonarkart C, Phakaratsakul S, et al
    Human Schlafen 11 inhibits influenza A virus production.
    Virus Res. 2023;334:199162.
    PubMed     Abstract available

  55. TAI W, Zheng J, Zhang X, Shi J, et al
    MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection.
    Virus Res. 2023;334:199156.
    PubMed     Abstract available

    May 2023
  56. ROY A, Sarkar A, Nayak D, Das S, et al
    Ultradiluted SARS-CoV-2 Spike Protein mitigates hyperinflammation in lung via ferritin and MMP-9 regulation in BALB/c mice.
    Virus Res. 2023;329:199091.
    PubMed     Abstract available

    April 2023
  57. NIE Y, Mou L, Long Q, Deng D, et al
    SARS-CoV-2 ORF3a positively regulates NF-kappaB activity by enhancing IKKbeta-NEMO interaction.
    Virus Res. 2023;328:199086.
    PubMed     Abstract available

  58. CUI X, Wang Y, Zhai J, Xue M, et al
    Future trajectory of SARS-CoV-2: Constant spillover back and forth between humans and animals.
    Virus Res. 2023;328:199075.
    PubMed     Abstract available

  59. CASTILLO G, Mora-Diaz JC, Breuer M, Singh P, et al
    Molecular mechanisms of human coronavirus NL63 infection and replication.
    Virus Res. 2023;327:199078.
    PubMed     Abstract available

    Possible spread of SARS-CoV-2 in domestic and wild animals and body temperature role.
    Virus Res. 2023;327:199066.
    PubMed     Abstract available

  61. TALUKDAR SN, Osan J, Ryan K, Grove B, et al
    RSV-induced expanded ciliated cells contribute to bronchial wall thickening.
    Virus Res. 2023;327:199060.
    PubMed     Abstract available

  62. ANDRES C, Del Cuerpo M, Rabella N, Pinana M, et al
    Detection of reassortant influenza B strains from 2004 to 2015 seasons in Barcelona (Catalonia, Spain) by whole genome sequencing.
    Virus Res. 2023 Apr 1:199089. doi: 10.1016/j.virusres.2023.199089.
    PubMed     Abstract available

    March 2023
  63. CHAPOLA H, de Bastiani MA, Duarte MM, Freitas MB, et al
    A comparative study of COVID-19 transcriptional signatures between clinical samples and preclinical cell models in the search for disease master regulators and drug repositioning candidates.
    Virus Res. 2023;326:199053.
    PubMed     Abstract available

  64. DARVISH M, Moosavi-Nejad Z, Siadat SOR, Fatemi F, et al
    Enhancing neutralizing antibodies against receptor binding domain of SARS-CoV-2 by a safe natural adjuvant system.
    Virus Res. 2023;326:199047.
    PubMed     Abstract available

    February 2023
  65. YATES PJ, Mehta N, Watson HA, Peppercorn AF, et al
    Lessons from resistance analysis in clinical trials of IV zanamivir.
    Virus Res. 2023;325:199039.
    PubMed     Abstract available

  66. GOYA S, Sosa E, Nabaes Jodar M, Torres C, et al
    Assessing the hidden diversity underlying consensus sequences of SARS-CoV-2 using VICOS, a novel bioinformatic pipeline for identification of mixed viral populations.
    Virus Res. 2023;325:199035.
    PubMed     Abstract available

    January 2023
  67. BRUNO A, Goni N, Cristina J
    Spatial, temporal and evolutionary insight into seasonal epidemic Influenza A virus strains near the equatorial line: The case of Ecuador.
    Virus Res. 2023;326:199051.
    PubMed     Abstract available

  68. JIN X, Liu X, Shen C
    A systemic review of T-cell epitopes defined from the proteome of SARS-CoV-2.
    Virus Res. 2023;324:199024.
    PubMed     Abstract available

    December 2022
  69. GALLI C, Pellegrinelli L, Giardina F, Ferrari G, et al
    On the lookout for influenza viruses in Italy during the 2021-2022 season: along came A(H3N2) viruses with a new phylogenetic makeup of their hemagglutinin.
    Virus Res. 2022 Dec 26:199033. doi: 10.1016/j.virusres.2022.199033.
    PubMed     Abstract available

  70. LIU YC, Liao GR, Tsai AY, Tseng CY, et al
    NS2 is a key determinant of compatibility in reassortant avian influenza virus with heterologous H7N9-derived NS segment.
    Virus Res. 2022 Dec 23:199028. doi: 10.1016/j.virusres.2022.199028.
    PubMed     Abstract available

  71. WANG Q, Zeng X, Tan S, Lan L, et al
    Pathogenicity and anti-infection immunity of animal H3N2 and H6N6 subtype influenza virus cross-species infection with tree shrews.
    Virus Res. 2022 Dec 18:199027. doi: 10.1016/j.virusres.2022.199027.
    PubMed     Abstract available

    November 2022
  72. RUANGRUNG K, Chakritbudsabong W, Thongon S, Rungarunlert S, et al
    Analysis of Influenza A virus infection in human induced pluripotent stem cells (hiPSCs) and their derivatives.
    Virus Res. 2022 Nov 19:199009. doi: 10.1016/j.virusres.2022.199009.
    PubMed     Abstract available

  73. SEMPLE SL, Alkie TN, Jenik K, Warner BM, et al
    More tools for our toolkit: The application of HEL-299 cells and dsRNA-nanoparticles to study human coronaviruses in vitro.
    Virus Res. 2022;321:198925.
    PubMed     Abstract available

  74. HU X, Cui J, Chen J, Du S, et al
    Identification of hACE2-interacting sites in SARS-CoV-2 spike receptor binding domain for antiviral drugs screening.
    Virus Res. 2022;321:198915.
    PubMed     Abstract available

  75. OLIVEIRA FADS, de Holanda MV, Lima LB, Dantas MB, et al
    Genomic surveillance: Circulating lineages and genomic variation of SARS-CoV-2 in early pandemic in Ceara state, Northeast Brazil.
    Virus Res. 2022;321:198908.
    PubMed     Abstract available

  76. DA SILVA MS, Gularte JS, Filippi M, Demoliner M, et al
    Genomic and epidemiologic surveillance of SARS-CoV-2 in Southern Brazil and identification of a new Omicron-L452R sublineage.
    Virus Res. 2022;321:198907.
    PubMed     Abstract available

  77. WANG B, Liu H
    Identification of potential immune/diagnosis related gene-immunocyte subtype networks in extracellular immune response to respiratory syncytial virus infection.
    Virus Res. 2022;321:198906.
    PubMed     Abstract available

    October 2022
  78. CHU JT, Gu H, Sun W, Fan RL, et al
    Heterosubtypic immune pressure accelerates emergence of influenza A virus escape phenotypes in mice.
    Virus Res. 2022 Oct 24:198991. doi: 10.1016/j.virusres.2022.198991.
    PubMed     Abstract available

  79. UPADHYAY M, Gupta S
    Endoplasmic reticulum secretory pathway: Potential target against SARS-CoV-2.
    Virus Res. 2022;320:198897.
    PubMed     Abstract available

  80. SOLOMON M, Liang C
    Human coronaviruses: The emergence of SARS-CoV-2 and management of COVID-19.
    Virus Res. 2022;319:198882.
    PubMed     Abstract available

  81. NAIDOO N, Moodley J, Khaliq OP, Naicker T, et al
    Neuropilin-1 in the pathogenesis of preeclampsia, HIV-1, and SARS-CoV-2 infection: A review.
    Virus Res. 2022;319:198880.
    PubMed     Abstract available

  82. GABER Y, Abdel Alem S, Musa S, Amer K, et al
    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulins using chemiluminescence immunoassay and its correlation with neutralizing antibodies.
    Virus Res. 2022;319:198852.
    PubMed     Abstract available

    September 2022
  83. LARBI I, Ghedira K, Marwa A, Butcher GD, et al
    Phylogenetic analysis and assessment of the pathogenic potential of the first H9N2 avian influenza viruses isolated from wild birds and lagoon water in Tunisia.
    Virus Res. 2022 Sep 17:198929. doi: 10.1016/j.virusres.2022.198929.
    PubMed     Abstract available

  84. HEIDER A, Wedde M, Durrwald R, Wolff T, et al
    Molecular characterization and evolution dynamics of influenza B viruses circulating in Germany from season 1996/1997 to 2019/2020.
    Virus Res. 2022 Sep 9:198926. doi: 10.1016/j.virusres.2022.198926.
    PubMed     Abstract available

  85. BHAT S, Rishi P, Chadha VD
    Understanding the epigenetic mechanisms in SARS CoV-2 infection and potential therapeutic approaches.
    Virus Res. 2022;318:198853.
    PubMed     Abstract available

  86. NUNES DBSM, Vieira C, Sa JM, Araujo GC, et al
    M2-2 gene as a new alternative molecular marker for phylogenetic, phylodynamic, and evolutionary studies of hRSV.
    Virus Res. 2022;318:198850.
    PubMed     Abstract available

  87. SHOKEEN K, Pandey S, Shah M, Kumar S, et al
    Insight towards the effect of the multi basic cleavage site of SARS-CoV-2 spike protein on cellular proteases.
    Virus Res. 2022;318:198845.
    PubMed     Abstract available

    August 2022
  88. SULTANKULOVA KT, Dzhekebekov KK, Orynbayev MB, Burashev YD, et al
    Evidence for flock transmission of individual subtypes and strains of avian influenza viruses: A monitoring study of wild birds in Kazakhstan.
    Virus Res. 2022 Aug 19:198898. doi: 10.1016/j.virusres.2022.198898.
    PubMed     Abstract available

  89. FAYAD N, Habib WA, El-Shesheny R, Kandeil A, et al
    Lebanese SARS-CoV-2 genomics: 24 months of the pandemic.
    Virus Res. 2022;317:198824.
    PubMed     Abstract available

    July 2022
  90. MEISTER TL, Gottsauner JM, Schmidt B, Heinen N, et al
    Mouthrinses against SARS-CoV-2 - High antiviral effectivity by membrane disruption in vitro translates to mild effects in a randomized placebo-controlled clinical trial.
    Virus Res. 2022;316:198791.
    PubMed     Abstract available

  91. ABDOLI M, Shafaati M, Ghamsari LK, Abdoli A, et al
    Intranasal administration of cold-adapted live-attenuated SARS-CoV-2 candidate vaccine confers protection against SARS-CoV-2.
    Virus Res. 2022 Jul 9:198857. doi: 10.1016/j.virusres.2022.198857.
    PubMed     Abstract available

  92. ALCANTARA LCJ, Nogueira E, Shuab G, Tosta S, et al
    SARS-CoV-2 epidemic in Brazil: how the displacement of variants has driven distinct epidemic waves.
    Virus Res. 2022;315:198785.
    PubMed     Abstract available

  93. DE AMARAL M, Ienes-Lima J
    Anurans against SARS-CoV-2: A review of the potential antiviral action of anurans cutaneous peptides.
    Virus Res. 2022;315:198769.
    PubMed     Abstract available

  94. GAIARSA S, Giardina F, Batisti Biffignandi G, Ferrari G, et al
    Comparative analysis of SARS-CoV-2 quasispecies in the upper and lower respiratory tract shows an ongoing evolution in the spike cleavage site.
    Virus Res. 2022;315:198786.
    PubMed     Abstract available

  95. SARKAR A, Paul S, Singh C, Chowdhury N, et al
    A novel plant lectin, NTL-125, interferes with SARS-CoV-2 interaction with hACE2.
    Virus Res. 2022;315:198768.
    PubMed     Abstract available

  96. BANSAL K, Kumar S
    Mutational cascade of SARS-CoV-2 leading to evolution and emergence of omicron variant.
    Virus Res. 2022;315:198765.
    PubMed     Abstract available

    June 2022
  97. PAZ M, Aldunate F, Arce R, Ferreiro I, et al
    An evolutionary insight into Severe Acute Respiratory Syndrome Coronavirus 2 Omicron variant of concern.
    Virus Res. 2022;314:198753.
    PubMed     Abstract available

    May 2022
  98. YANG F, Zhu L, Liu F, Cheng L, et al
    Generation and characterization of monoclonal antibodies against the hemagglutinin of H3N2 influenza A viruses.
    Virus Res. 2022 May 17:198815. doi: 10.1016/j.virusres.2022.198815.
    PubMed     Abstract available

  99. MAITI AK
    Evolutionary shift from purifying selection towards divergent selection of SARS-CoV2 favors its invasion into multiple human organs.
    Virus Res. 2022;313:198712.
    PubMed     Abstract available

    April 2022
  100. ALMEIDA F, Santos LA, Trigueiro-Louro JM, RebelodeAndrade H, et al
    Optimization of A(H1N1)pdm09 vaccine seed viruses: the source of PB1 and HA vRNA as a major determinant for antigen yield.
    Virus Res. 2022 Apr 30:198795. doi: 10.1016/j.virusres.2022.198795.
    PubMed     Abstract available

  101. WEI N, Wang Q, Lin Z, Xu L, et al
    Systematic profiling of antigen bias in humoral response against SARS-CoV-2.
    Virus Res. 2022;312:198711.
    PubMed     Abstract available

  102. KOBAYASHI D, Hiono T, Ichii O, Nishihara S, et al
    Turkeys possess div6erse Siaalpha2-3Gal glycans that facilitate their dual susceptibility to avian influenza viruses isolated from ducks and chickens.
    Virus Res. 2022 Apr 13:198771. doi: 10.1016/j.virusres.2022.198771.
    PubMed     Abstract available

  103. GULARTE JS, da Silva MS, Mosena ACS, Demoliner M, et al
    Early introduction, dispersal and evolution of Delta SARS-CoV-2 in Southern Brazil, late predominance of AY.99.2 and AY.101 related lineages.
    Virus Res. 2022;311:198702.
    PubMed     Abstract available

  104. MIYAOKA Y, Yamaguchi M, Kadota C, Hasan MA, et al
    Rapid in vitro virucidal activity of slightly acidic hypochlorous acid water toward aerosolized coronavirus in simulated human-dispersed droplets.
    Virus Res. 2022;311:198701.
    PubMed     Abstract available

    March 2022
  105. ARBI M, Larbi I, Nsiri J, Behi IE, et al
    Inhibition of avian influenza virus H9N2 infection by antiviral hexapeptides that target viral attachment to epithelial cells.
    Virus Res. 2022;313:198745.
    PubMed     Abstract available

  106. GERDOL M, Dishnica K, Giorgetti A
    Emergence of a recurrent insertion in the N-terminal domain of the SARS-CoV-2 spike glycoprotein.
    Virus Res. 2022;310:198674.
    PubMed     Abstract available

  107. MOHEBALI M, Hassanpour G, Zainali M, Gouya MM, et al
    SARS-CoV-2 in domestic cats (Felis catus) in the northwest of Iran: Evidence for SARS-CoV-2 circulating between human and cats.
    Virus Res. 2022;310:198673.
    PubMed     Abstract available

    February 2022
  108. DING XM, Wang YF, Lyu Y, Zou Y, et al
    The effect of influenza A (H1N1) pdm09 virus infection on cytokine production and gene expression in BV2 microglial cells.
    Virus Res. 2022 Feb 28:198716. doi: 10.1016/j.virusres.2022.198716.
    PubMed     Abstract available

    January 2022
  109. PERBOLIANACHIS P, Ferla D, Arce R, Ferreiro I, et al
    Phylogenetic analysis of SARS-CoV-2 viruses circulating in the South American region: genetic relations and vaccine strain match.
    Virus Res. 2022 Jan 21:198688. doi: 10.1016/j.virusres.2022.198688.
    PubMed     Abstract available

  110. SLAVOV SN, Bezerra RDS, Rodrigues ES, Santos EV, et al
    Genomic monitoring of the SARS-CoV-2 B1.1.7 (WHO VOC Alpha) in the Sao Paulo state, Brazil.
    Virus Res. 2022;308:198643.
    PubMed     Abstract available

  111. KUMAR S, Bansal K
    Cross-sectional genomic perspective of epidemic waves of SARS-CoV-2: A pan India study.
    Virus Res. 2022;308:198642.
    PubMed     Abstract available

  112. PAUL S, Bravo Vazquez LA, Reyes-Perez PR, Estrada-Meza C, et al
    The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review.
    Virus Res. 2022;308:198631.
    PubMed     Abstract available

  113. ALVAREZ-DIAZ DA, Laiton-Donato K, Torres-Garcia OA, Ruiz-Moreno HA, et al
    Reduced levels of convalescent neutralizing antibodies against SARS-CoV-2 B.1+L249S+E484K lineage.
    Virus Res. 2022;308:198629.
    PubMed     Abstract available

  114. PRATHIVIRAJ R, Chellapandi P, Begum A, Kiran GS, et al
    Identification of genotypic variants and its proteomic mutations of Brazilian SARS-CoV-2 isolates.
    Virus Res. 2022;307:198618.
    PubMed     Abstract available

    December 2021
  115. YANG F, Dong D, Wu D, Zhu L, et al
    A multiplex real-time RT-PCR method for detecting H5, H7 and H9 subtype avian influenza viruses in field and clinical samples.
    Virus Res. 2021;309:198669.
    PubMed     Abstract available

  116. NISHIOKA K, Daidoji T, Nakaya T
    Downregulation of calcium-regulated heat stable protein 1 expression by low-temperature stimulation causes reduction of interferon-beta expression and sensitivity to influenza viral infection.
    Virus Res. 2021;309:198659.
    PubMed     Abstract available

  117. PORTER WT, Kelley EJ, Bowers JR, Engelthaler DM, et al
    Normalization of SARS-CoV-2 viral load via RT-qPCR provides higher-resolution data for comparison across time and between patients.
    Virus Res. 2021;306:198604.
    PubMed     Abstract available

    November 2021
  118. LEE TY, Lee H, Kim N, Jeon P, et al
    Comparison of SARS-CoV-2 variant lethality in human angiotensin-converting enzyme 2 transgenic mice.
    Virus Res. 2021;305:198563.
    PubMed     Abstract available

  119. WANG W, Li CP, He M, Li SW, et al
    The dominant strain of SARS-CoV-2 is a mosaicism.
    Virus Res. 2021;305:198553.
    PubMed     Abstract available

  120. BUKIN YS, Bondaryuk AN, Kulakova NV, Balakhonov SV, et al
    Phylogenetic reconstruction of the initial stages of the spread of the SARS-CoV-2 virus in the Eurasian and American continents by analyzing genomic data.
    Virus Res. 2021;305:198551.
    PubMed     Abstract available

  121. TAVAKOLI F, Izadi A, Yavarian J, Sharifi-Zarchi A, et al
    Determination of genetic characterization and circulation pattern of Respiratory Syncytial Virus (RSV) in children with a respiratory infection, Tehran, Iran, during 2018-2019.
    Virus Res. 2021;305:198564.
    PubMed     Abstract available

  122. GUPTA D, Parthasarathy H, Sah V, Tandel D, et al
    Inactivation of SARS-CoV-2 by beta-propiolactone causes aggregation of viral particles and loss of antigenic potential.
    Virus Res. 2021;305:198555.
    PubMed     Abstract available

  123. BOSE T, Pant N, Pinna NK, Bhar S, et al
    Does immune recognition of SARS-CoV2 epitopes vary between different ethnic groups?
    Virus Res. 2021;305:198579.
    PubMed     Abstract available

  124. PRATELLI A, Lucente MS, Mari V, Cordisco M, et al
    A simple pooling salivary test for SARS-CoV-2 diagnosis: A Columbus' egg?
    Virus Res. 2021;305:198575.
    PubMed     Abstract available

    October 2021
  125. FRANCESCHI VB, Ferrareze PAG, Zimerman RA, Cybis GB, et al
    Mutation hotspots and spatiotemporal distribution of SARS-CoV-2 lineages in Brazil, February 2020-2021.
    Virus Res. 2021;304:198532.
    PubMed     Abstract available

  126. HUANG X, Zhang F, Zhu K, Lin W, et al
    dsmCRISPR: Dual synthetic mismatches CRISPR/Cas12a-based detection of SARS-CoV-2 D614G mutation.
    Virus Res. 2021;304:198530.
    PubMed     Abstract available

  127. FORT H
    A very simple model to account for the rapid rise of the alpha variant of SARS-CoV-2 in several countries and the world.
    Virus Res. 2021;304:198531.
    PubMed     Abstract available

  128. VALE FF, Vitor JMB, Marques AT, Azevedo-Pereira JM, et al
    Origin, phylogeny, variability and epitope conservation of SARS-CoV-2 worldwide.
    Virus Res. 2021;304:198526.
    PubMed     Abstract available

  129. ZHAO J, Wang L, Schank M, Dang X, et al
    SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects.
    Virus Res. 2021;304:198508.
    PubMed     Abstract available

  130. YAMAYA M, Deng X, Kikuchi A, Sugawara M, et al
    The proton ATPase inhibitor bafilomycin A1 reduces the release of rhinovirus C and cytokines from primary cultures of human nasal epithelial cells.
    Virus Res. 2021;304:198548.
    PubMed     Abstract available

  131. KHAN S, Dobrovolny HM
    A study of the effects of age on the dynamics of RSV in animal models.
    Virus Res. 2021;304:198524.
    PubMed     Abstract available

  132. KANNIAN P, Jayaraman BG, Alamelu S, Lavanya C, et al
    Implications in the quantification of SARS-CoV2 copies in concurrent nasopharyngeal swabs, whole mouth fluid and respiratory droplets.
    Virus Res. 2021;303:198442.
    PubMed     Abstract available

    September 2021
  133. YANG F, Xiao Y, Liu F, Yao H, et al
    Molecular Characterization and Antigenic analysis of reassortant H9N2 subtype avian influenza viruses in Eastern China in 2016.
    Virus Res. 2021 Sep 21:198577. doi: 10.1016/j.virusres.2021.198577.
    PubMed     Abstract available

  134. YE H, Bi Z, Fan W, Song S, et al
    Cellular hnRNPAB interacts with avian influenza viral protein PB2 and inhibits virus replication potentially by restricting PB2 mRNA nuclear export and PB2 protein level.
    Virus Res. 2021 Sep 20:198573. doi: 10.1016/j.virusres.2021.198573.
    PubMed     Abstract available

  135. HAQUE MFU, Bukhari SS, Ejaz R, Zaman FU, et al
    A novel RdRp-based colorimetric RT-LAMP assay for rapid and sensitive detection of SARS-CoV-2 in clinical and sewage samples from Pakistan.
    Virus Res. 2021;302:198484.
    PubMed     Abstract available

  136. GORAICHUK IV, Arefiev V, Stegniy BT, Gerilovych AP, et al
    Zoonotic and Reverse Zoonotic Transmissibility of SARS-CoV-2.
    Virus Res. 2021;302:198473.
    PubMed     Abstract available

  137. EMAM M, Oweda M, Antunes A, El-Hadidi M, et al
    Positive selection as a key player for SARS-CoV-2 pathogenicity: Insights into ORF1ab, S and E genes.
    Virus Res. 2021;302:198472.
    PubMed     Abstract available

  138. STEGMANN KM, Dickmanns A, Gerber S, Nikolova V, et al
    The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models.
    Virus Res. 2021;302:198469.
    PubMed     Abstract available

    August 2021
  139. BURNHAM AJ, Miller JR, Singh I, Billings EA, et al
    Novel isoforms of influenza virus PA-X and PB1-F2 indicated by automatic annotation.
    Virus Res. 2021 Aug 12:198545. doi: 10.1016/j.virusres.2021.198545.
    PubMed     Abstract available

  140. POLICARD M, Jain S, Rego S, Dakshanamurthy S, et al
    Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism.
    Virus Res. 2021;301:198464.
    PubMed     Abstract available

    July 2021
  141. TIAN X, Mo C, Zhou L, Yang Y, et al
    Epitope mapping of severe acute respiratory syndrome-related coronavirus nucleocapsid protein with a rabbit monoclonal antibody.
    Virus Res. 2021;300:198445.
    PubMed     Abstract available

  142. HASSAN SS, Attrish D, Ghosh S, Choudhury PP, et al
    Pathogenic perspective of missense mutations of ORF3a protein of SARS-CoV-2.
    Virus Res. 2021;300:198441.
    PubMed     Abstract available

  143. ABBASI S, Hosseinkhan N, Shafiei Jandaghi NZ, Sadeghi K, et al
    Impact of human rhinoviruses on gene expression in pediatric patients with severe acute respiratory infection.
    Virus Res. 2021;300:198408.
    PubMed     Abstract available

  144. RODRIGUEZ T, Dobrovolny HM
    Quantifying the effect of trypsin and elastase on in vitro SARS-CoV infections.
    Virus Res. 2021;299:198423.
    PubMed     Abstract available

  145. SALEHI-VAZIRI M, Omrani MD, Pouriayevali MH, Fotouhi F, et al
    SARS-CoV-2 presented moderately during two episodes of the infection with lack of antibody responses.
    Virus Res. 2021;299:198421.
    PubMed     Abstract available

  146. ALTABLE M, de la Serna JM
    Protection against COVID-19 in African population: Immunology, genetics, and malaria clues for therapeutic targets.
    Virus Res. 2021;299:198347.
    PubMed     Abstract available

    June 2021
  147. GHOSH N, Saha I, Sharma N, Nandi S, et al
    Genome-wide analysis of 10664 SARS-CoV-2 genomes to identify virus strains in 73 countries based on single nucleotide polymorphism.
    Virus Res. 2021;298:198401.
    PubMed     Abstract available

    Viral Vector DNA- and RNA-Based SARS-CoV-2 Vaccines: Possible Integration into the Human Genome Are Adenoviral Genes Expressed in Vector-based Vaccines?
    Virus Res. 2021 Jun 1:198466. doi: 10.1016/j.virusres.2021.198466.
    PubMed     Abstract available

  149. LEI L, Qin H, Luo J, Tan Y, et al
    Construction and immunological evaluation of hepatitis B virus core virus-like particles containing multiple antigenic peptides of respiratory syncytial virus.
    Virus Res. 2021;298:198410.
    PubMed     Abstract available

    May 2021
  150. CARNEIRO DC, Sousa JD, Monteiro-Cunha JP
    The COVID-19 Vaccine Development: A Pandemic Paradigm.
    Virus Res. 2021 May 17:198454. doi: 10.1016/j.virusres.2021.198454.
    PubMed     Abstract available

  151. LEE S, Won D, Kim CK, Ahn J, et al
    Novel indel mutation in the N gene of SARS-CoV-2 clinical samples that were diagnosed positive in a commercial RT-PCR assay.
    Virus Res. 2021;297:198398.
    PubMed     Abstract available

  152. HASAN MM, Das R, Rasheduzzaman M, Hussain MH, et al
    Global and local mutations in Bangladeshi SARS-CoV-2 genomes.
    Virus Res. 2021;297:198390.
    PubMed     Abstract available

  153. RUIZ-GOMEZ X, Vazquez-Perez JA, Flores-Herrera O, Esparza-Perusquia M, et al
    Steady-state persistence of respiratory syncytial virus in a macrophage-like cell line and sequence analysis of the persistent viral genome.
    Virus Res. 2021;297:198367.
    PubMed     Abstract available

    April 2021
  154. FRANCISCO RDS JR, Benites LF, Lamarca AP, de Almeida LGP, et al
    Pervasive transmission of E484K and emergence of VUI-NP13L with evidence of SARS-CoV-2 co-infection events by two different lineages in Rio Grande do Sul, Brazil.
    Virus Res. 2021;296:198345.
    PubMed     Abstract available

  155. MIRANDA RL, Guterres A, de Azeredo Lima CH, Filho PN, et al
    Misinterpretation of viral load in COVID-19 clinical outcomes.
    Virus Res. 2021;296:198340.
    PubMed     Abstract available

  156. LI JY, Wang Q, Liao CH, Qiu Y, et al
    The 442th amino acid residue of the spike protein is critical for the adaptation to bat hosts for SARS-related coronaviruses.
    Virus Res. 2021;295:198307.
    PubMed     Abstract available

  157. SCAGNOLARI C, Pierangeli A, Frasca F, Bitossi C, et al
    Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19).
    Virus Res. 2021;295:198283.
    PubMed     Abstract available

  158. HU Z, Zhao J, Shi L, Hu J, et al
    Identification of the dominant non-neutralizing epitope in the haemagglutinin of H7N9 avian influenza virus.
    Virus Res. 2021;298:198409.
    PubMed     Abstract available

  159. NIYOMDECHA N, Suptawiwat O, Boonarkart C, Thitithanyanont A, et al
    Repurposing of antiparasitic niclosamide to inhibit respiratory syncytial virus (RSV) replication.
    Virus Res. 2021;295:198277.
    PubMed     Abstract available

    March 2021
  160. LANDGRAF G, Desheva YA, Rudenko LG
    Evaluation of influenza A and B cold-adapted reassortant virus reproduction in trivalent live influenza vaccines.
    Virus Res. 2021 Mar 17:198396. doi: 10.1016/j.virusres.2021.198396.
    PubMed     Abstract available

  161. MIYAOKA Y, Kabir H, Hasan A, Yamaguchi M, et al
    Virucidal activity of slightly acidic hypochlorous acid water toward influenza virus and coronavirus with tests simulating practical usage.
    Virus Res. 2021 Mar 8:198383. doi: 10.1016/j.virusres.2021.198383.
    PubMed     Abstract available

  162. SAFARI F, Afarid M, Rastegari B, Borhani-Haghighi A, et al
    CRISPR systems: Novel approaches for detection and combating COVID-19.
    Virus Res. 2021;294:198282.
    PubMed     Abstract available

  163. TAN J, Yuan Y, Xu C, Song C, et al
    A retrospective comparison of drugs against COVID-19.
    Virus Res. 2021;294:198262.
    PubMed     Abstract available

    February 2021
  164. KIM DH, Park BJ, Ahn HS, Go HJ, et al
    Canine interferon lambda 3 expressed using an adenoviral vector effectively induces antiviral activity against canine influenza virus.
    Virus Res. 2021 Feb 16:198342. doi: 10.1016/j.virusres.2021.198342.
    PubMed     Abstract available

  165. RIVERA-BAHENA GB, Marquez-Bandala AH, Lopez-Guerrero DV, Esquivel-Guadarrama FR, et al
    TGF-beta1 signaling inhibit the in vitro apoptotic, infection and stimulatory cell response induced by influenza H1N1 virus infection on A549 cells.
    Virus Res. 2021 Feb 10:198337. doi: 10.1016/j.virusres.2021.198337.
    PubMed     Abstract available

  166. LI B, Xiang G, He J, Li H, et al
    H7N9 influenza virus surveillance in Gansu, China in 2017.
    Virus Res. 2021 Feb 9:198335. doi: 10.1016/j.virusres.2021.198335.
    PubMed     Abstract available

  167. DE CONTO F, Conversano F, Razin SV, Belletti S, et al
    Host-cell dependent role of phosphorylated keratin 8 during influenza A/NWS/33 virus (H1N1) infection in mammalian cells.
    Virus Res. 2021 Feb 5:198333. doi: 10.1016/j.virusres.2021.198333.
    PubMed     Abstract available

  168. AKIYAMA Y, Sakashita K, Arihara M, Kimura Y, et al
    COVID-19 infection in Hokkaido, Japan might depend on the viscosity of atmospheric air.
    Virus Res. 2021;293:198259.
    PubMed     Abstract available

  169. ITO G, Morikawa M, Akimoto S, Masatani T, et al
    Establishment of a safe and convenient assay for detection of HA subtype-specific antibodies with PB2 gene-knockout influenza viruses.
    Virus Res. 2021 Feb 1:198331. doi: 10.1016/j.virusres.2021.198331.
    PubMed     Abstract available

    January 2021
  170. LUBAN J, Sattler RA, Muhlberger E, Graci JD, et al
    The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines.
    Virus Res. 2021;292:198246.
    PubMed     Abstract available

  171. KUMAR R, Rathi H, Haq A, Wimalawansa SJ, et al
    Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19.
    Virus Res. 2021;292:198235.
    PubMed     Abstract available

  172. JOONLASAK K, Batty EM, Kochakarn T, Panthan B, et al
    Genomic surveillance of SARS-CoV-2 in Thailand reveals mixed imported populations, a local lineage expansion and a virus with truncated ORF7a.
    Virus Res. 2021;292:198233.
    PubMed     Abstract available

  173. MALEK A, Hoque A
    Trends of 2019-nCoV in South Asian countries and prediction of the epidemic peaks.
    Virus Res. 2021;292:198230.
    PubMed     Abstract available

  174. CATTEL F, Giordano S, Bertiond C, Lupia T, et al
    Ozone therapy in COVID-19: A narrative review.
    Virus Res. 2021;291:198207.
    PubMed     Abstract available

  175. PIERETTI JC, Rubilar O, Weller RB, Tortella GR, et al
    Nitric oxide (NO) and nanoparticles - Potential small tools for the war against COVID-19 and other human coronavirus infections.
    Virus Res. 2021;291:198202.
    PubMed     Abstract available

  176. CABBAB ILN, Manalo RVM
    Anti-inflammatory drugs and the renin-angiotensin-aldosterone system: Current knowledge and potential effects on early SARS-CoV-2 infection.
    Virus Res. 2021;291:198190.
    PubMed     Abstract available

    December 2020
  177. TAHAGHOGHI-HAJGHORBANI S, Zafari P, Masoumi E, Rajabinejad M, et al
    The role of dysregulated immune responses in COVID-19 pathogenesis.
    Virus Res. 2020;290:198197.
    PubMed     Abstract available

  178. RAJEEV R, Prathiviraj R, Kiran GS, Selvin J, et al
    Zoonotic evolution and implications of microbiome in viral transmission and infection.
    Virus Res. 2020;290:198175.
    PubMed     Abstract available

  179. KILLICK R, Ballard C, Doherty P, Williams G, et al
    Transcription-based drug repurposing for COVID-19.
    Virus Res. 2020;290:198176.
    PubMed     Abstract available

  180. KHARE P, Sahu U, Pandey SC, Samant M, et al
    Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.
    Virus Res. 2020;290:198169.
    PubMed     Abstract available

  181. FREIRE-PASPUEL B, Vega-Marino P, Velez A, Cruz M, et al
    "Sample pooling of RNA extracts to speed up SARS-CoV-2 diagnosis using CDC FDA EUA RT-qPCR kit".
    Virus Res. 2020;290:198173.
    PubMed     Abstract available

  182. YAMASAKI Y, Ooka S, Tsuchida T, Nakamura Y, et al
    The peripheral lymphocyte count as a predictor of severe COVID-19 and the effect of treatment with ciclesonide.
    Virus Res. 2020;290:198089.
    PubMed     Abstract available

    November 2020
  183. WEBER S, Ramirez C, Doerfler W
    Signal hotspot mutations in SARS-CoV-2 genomes evolve as the virus spreads and actively replicates in different parts of the world.
    Virus Res. 2020;289:198170.
    PubMed     Abstract available

  184. GADOTTI AC, de Castro Deus M, Telles JP, Wind R, et al
    IFN-gamma is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection.
    Virus Res. 2020;289:198171.
    PubMed     Abstract available

  185. RANGEL HR, Ortega JT, Maksoud S, Pujol FH, et al
    SARS-CoV-2 host tropism: An in silico analysis of the main cellular factors.
    Virus Res. 2020;289:198154.
    PubMed     Abstract available

  186. ELHABYAN A, Elyaacoub S, Sanad E, Abukhadra A, et al
    The role of host genetics in susceptibility to severe viral infections in humans and insights into host genetics of severe COVID-19: A systematic review.
    Virus Res. 2020;289:198163.
    PubMed     Abstract available

  187. WANG X, Zheng J, Guo L, Yao H, et al
    Fecal viral shedding in COVID-19 patients: Clinical significance, viral load dynamics and survival analysis.
    Virus Res. 2020;289:198147.
    PubMed     Abstract available

  188. MARDANI R, Alamdary A, Mousavi Nasab SD, Gholami R, et al
    Association of vitamin D with the modulation of the disease severity in COVID-19.
    Virus Res. 2020;289:198148.
    PubMed     Abstract available

  189. CHOUDHARY S, Silakari O
    Scaffold morphing of arbidol (umifenovir) in search of multi-targeting therapy halting the interaction of SARS-CoV-2 with ACE2 and other proteases involved in COVID-19.
    Virus Res. 2020;289:198146.
    PubMed     Abstract available

    October 2020
  190. ZHOU Y, Wu X, Yan D, Chen C, et al
    V292I Mutation in PB2 Polymerase Induces Increased Effects of E627K on Influenza H7N9 Virus Replication in Cells.
    Virus Res. 2020 Oct 16:198186. doi: 10.1016/j.virusres.2020.198186.
    PubMed     Abstract available

  191. YOKOYAMA Y, Briasoulis A, Takagi H, Kuno T, et al
    Effect of remdesivir on patients with COVID-19: A network meta-analysis of randomized control trials.
    Virus Res. 2020;288:198137.
    PubMed     Abstract available

  192. ALI Z, Aman R, Mahas A, Rao GS, et al
    iSCAN: An RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2.
    Virus Res. 2020;288:198129.
    PubMed     Abstract available

  193. DUTTA R, Buragohain L, Borah P
    Analysis of codon usage of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) and its adaptability in dog.
    Virus Res. 2020;288:198113.
    PubMed     Abstract available

  194. MOHAMMAD T, Shamsi A, Anwar S, Umair M, et al
    Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy.
    Virus Res. 2020;288:198102.
    PubMed     Abstract available

  195. SITARAS I, Spackman E, de Jong MCM, Parris DJ, et al
    Selection and Antigenic Characterization of Immune-Escape Mutants of H7N2 Low Pathogenic Avian Influenza Virus Using Homologous Polyclonal Sera.
    Virus Res. 2020 Oct 9:198188. doi: 10.1016/j.virusres.2020.198188.
    PubMed     Abstract available

    August 2020
  196. SAMRAT SK, Tharappel AM, Li Z, Li H, et al
    Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development.
    Virus Res. 2020 Aug 23:198141. doi: 10.1016/j.virusres.2020.198141.
    PubMed     Abstract available

  197. KAUR SP, Gupta V
    COVID-19 Vaccine: A comprehensive status report.
    Virus Res. 2020 Aug 12:198114. doi: 10.1016/j.virusres.2020.198114.
    PubMed     Abstract available

    July 2020
  198. LIN L, Ting S, Yufei H, Wendong L, et al
    Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2.
    Virus Res. 2020 Jul 1:198082. doi: 10.1016/j.virusres.2020.198082.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.